INTS
insider transactionsINTENSITY THERAPEUTICS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Lewis H Bender KEY
President and CEO
$230.6K
37.7K sh · $6.11
Own +47%
-
Grant·A
Principal Accounting Officer
$2.3K
8.9K sh · $0.26
Own +12%
-
Grant·A
Joseph Talamo KEY
Chief Financial Officer
$3.8K
14.5K sh · $0.26
Own +102%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Mar 26, 2026 | Lewis H Bender KEY | Grant A | 37.7K | $230.6K |
| Dec 31, 2025 | John M Wesolowski | Grant A | 8.9K | $2.3K |
| Dec 31, 2025 | Joseph Talamo KEY | Grant A | 14.5K | $3.8K |
About INTS insider trading
This page tracks insider transactions for INTENSITY THERAPEUTICS, INC. (INTS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.